Facile synthesis of indole heterocyclic compounds based micellar nano anti-cancer drugs

46Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

Abstract

Facile synthesis of micellar “nano” indole heterocyclic anti-cancer compounds is described. The synthesized compounds (11-23) were characterized by UV-VIS, 1H NMR, FT-IR and mass spectroscopy. The binding energies of DNA-compound adducts varied from −20.08 to −23.85 kJ mol−1, and they were stabilized by hydrophobic interactions and H-bonding. The synthesized compounds enter into minor grooves of DNA during adduct formation. The DNA binding constant of compounds 11-23 was 1.00 to 2.00 × 105 M−1. The drug-loading efficiency and drug-loading content in their micellar forms were recorded. Compounds 11, 12, 14 and 19 at a micellar concentration of 670 μL mL−1 displayed excellent anticancer activities against the HepG2/C3A line (25-50%). The potency of nano anticancer drugs was predicted by drug likeness using Lipinski's “rule of five”. Taken together, compounds 11-23 could be used to treat cancers.

Cite

CITATION STYLE

APA

Ali, I., Mukhtar, S. D., Hsieh, M. F., Alothman, Z. A., & Alwarthan, A. (2018). Facile synthesis of indole heterocyclic compounds based micellar nano anti-cancer drugs. RSC Advances, 8(66), 37905–37914. https://doi.org/10.1039/C8RA07060A

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free